Recent studies had revealed that AIM2 enhanced the stability of Treg cells by attenuating AKT phosphorylation, mTOR and MYC signaling, and glycolysis, while promoting lipid oxidative phosphorylation, thereby ameliorating autoimmune diseases (32). This evidence concerns the gene MTOR and autoimmune disease.